Seeking Alpha

Noble Corporation has recently emerged from Chapter 11 and is drawing investor interest. We find this surprising at current…

Bristol-Myers Squibb stock appears ready for a new valuation and trading range, where the low to mid $60s should…

A broad last-day rally helped the major averages cement their third-straight weekly gain, overcoming choppy trading in the holiday-shortened…

The quality factor is subject to greater differentiation in definition than factors like beta, value and size.

CrowdStrike has shown a tremendous ability to grow through net new customer additions, ARR, revenue growth and retention rates….

CrowdStrike’s current valuation may be asking a bit too much from new investors. Read why we advise a bit…

Bandai Namco has shown that it has a resilient and defensive business model during the pandemic but its performance…

Both Taiwan Semiconductor and United Microelectronics are expected to benefit from the chip-supply crisis. Read more to see which…

Given its opportunity and technology, a market cap <$350m looks too low for Oncorus, in my view.

A hugely profitable Altria pays high dividends. The company has a low valuation and a hidden asset of BUD…